FIA
SILK

FNY Investment Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

FNY Investment Advisers’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,458
Closed -$70K – 1216
2019
Q2 		$70K Buy
+1,458
New +$62K 0.02% 328

Other funds holding SILK

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FNY Investment Advisers's SILK Position: Q3 2019 in Review

FNY Investment Advisers sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2019, closing a stake of 1,458 shares — an estimated $70K sold.

FNY Investment Advisers first reported a position in SILK in Q2 2019 and held it in 1 quarter. The position peaked at $70K in Q2 2019. 101 funds tracked by Wall St. Rank hold SILK as of Q3 2019.

  • FNY Investment Advisers reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 1,458 Silk Road Medical, Inc. Common Stock shares in Q3 2019, an estimated $70K.
  • FNY Investment Advisers first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • FNY Investment Advisers's Silk Road Medical, Inc. Common Stock position peaked at $70K in Q2 2019.
  • 101 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.